NOVACCESS GLOBAL INC (XSNX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 12, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for FY2024, filed Jan 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the XSNX SEC filings page.
NOVACCESS GLOBAL INC (XSNX) reported $0 in revenue for fiscal year 2024. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The reported balance sheet is dominated by obligations, while financing inflows largely offset operating cash use rather than funding expansion.
By FY2024, total liabilities of$10.1M towered over$62K of total assets, making the balance sheet obligation-heavy rather than asset-backed. That imbalance coincided with negative equity of$10.0M and a current ratio of 0.0x, indicating that near-term claims were not matched by reported current resources.
In FY2024, operating cash flow was
The latest liquidity comparison equaled 1.2 months of reported annual outflow, while current liabilities equaled
Financial Health Signals
NOVACCESS GLOBAL INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2024.
Cash & Balance Sheet
NOVACCESS GLOBAL INC held $21K in cash as of Q4 2024; long-term debt is not reported for that period.
Not reported for Q4 2024.
Not reported for Q4 2024.
Margins & Returns
None of these metrics is reported for Q4 2024.
Capital Allocation
None of these metrics is reported for Q4 2024.
XSNX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | $0 | $0 | $0 | N/A | $0 | $0 | $0 |
| Cost of Revenue | N/A | $0 | $0 | $0 | N/A | $0 | $0 | $0 |
| Gross Profit | N/A | $0 | $0 | $0 | N/A | $0 | $0 | $0 |
| R&D Expenses | N/A | $37K-7.1% | $36K-11.6% | $50K+42.1% | N/A | $40K-21.5% | $41K-9.8% | $35K-17.5% |
| SG&A Expenses | N/A | $278K-37.4% | $196K | N/A | N/A | $444K+62.4% | N/A | N/A |
| Operating Income | N/A | -$315K+34.9% | -$233K | N/A | N/A | -$485K-49.2% | N/A | N/A |
| Interest Expense | N/A | $186K-37.1% | $106K-59.4% | $72K | N/A | $295K-43.4% | $262K+2.6% | N/A |
| Net Income | N/A | -$936K-20.1% | N/A | N/A | N/A | -$780K-67.1% | $454K | N/A |
| EPS (Basic) | N/A | -$0.02+50.0% | -$0.02-200.0% | $0.06+142.9% | -$0.08-900.0% | -$0.04-33.3% | $0.02+125.0% | -$0.14-1300.0% |
| EPS (Diluted) | N/A | -$0.02 | -$0.02 | $0.01+107.1% | -$0.08-900.0% | -$0.04-33.3% | -$0.03+62.5% | -$0.14-1300.0% |
| Diluted Shares (Avg) | N/A | 54M | 28M | 96M+405.5% | N/A | 21M+17.7% | 46M+196.5% | 19M+31.3% |
Not reported in any period shown, so not listed: EBITDA, Income Tax.
XSNX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $62K0.0% | $274K+54.5% | $86K-17.2% | $17K-70.4% | $62K-50.2% | $177K-6.6% | $103K+23.9% | $59K+62.5% |
| Current Assets | $62K0.0% | $52K | N/A | N/A | $62K | N/A | N/A | N/A |
| Cash & Equivalents | $21K-2.4% | $794-98.7% | $10K-55.4% | $2K-96.1% | $21K-66.7% | $61K-31.7% | $22K-64.3% | $39K+57.7% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $10.1M+28.3% | $7.7M+20.1% | $6.9M+19.0% | $6.4M-9.0% | $7.9M+64.5% | $6.4M+33.7% | $5.8M+24.5% | $7.1M+75.9% |
| Current Liabilities | $10.1M+28.3% | $7.7M+20.1% | $6.9M+19.0% | $6.4M-9.0% | $7.9M+64.5% | $6.4M+38.5% | $5.8M+29.1% | $7.1M+83.5% |
| Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0-100.0% | $0-100.0% | $0-100.0% |
| Total Equity | -$10.0M-28.5% | -$7.4M-19.1% | -$6.9M-19.7% | -$6.4M+8.5% | -$7.8M-67.6% | -$6.2M-35.4% | -$5.7M-24.5% | -$7.0M-76.0% |
| Retained Earnings | -$69.6M-4.0% | -$67.0M-2.9% | -$66.1M-2.7% | -$65.6M-1.2% | -$66.9M-7.6% | -$65.1M-4.9% | -$64.4M-4.1% | -$64.8M-6.9% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
XSNX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$55K+64.2% | -$59K+48.0% | -$61K+69.0% | -$40K+74.9% | -$155K+21.6% | -$113K+57.6% | -$197K+20.7% | -$159K |
| Stock-Based Compensation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0-100.0% |
| Investing Cash Flow | $0 | N/A | N/A | N/A | $0 | N/A | N/A | N/A |
| Financing Cash Flow | $76K-34.2% | $50K-67.4% | $70K-61.4% | $20K-85.1% | $115K-33.2% | $153K-48.3% | $180K-36.9% | $134K+293.0% |
Not reported in any period shown, so not listed: Depreciation & Amortization, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
XSNX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, FCF Margin.
Note: Shareholder equity is negative (-$10.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| NOVACCESS GLOBAL INC XSNX | FY2024 | $0 | N/A | N/A | $6K | — |
| BETTER THERAPEUTICS INC BTTX | FY2022 | N/A | -$39.8M | N/A | $5K | — |
| RENOVACARE INC RCAR | FY2021 | N/A | -$4.5M | N/A | $9K | — |
| COMERA LIFE SCIENCES HLDG CMRA | FY2022 | $633K | -$18.0M | N/A | $6K | — |
| VIRPAX PHARMS INC VRPX | FY2024 | N/A | N/A | N/A | N/A | — |
Where NOVACCESS GLOBAL INC Ranks
Frequently Asked Questions
What is NOVACCESS GLOBAL INC's annual revenue?
NOVACCESS GLOBAL INC (XSNX) reported $0 in total revenue for fiscal year 2024. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
What is NOVACCESS GLOBAL INC's operating cash flow?
NOVACCESS GLOBAL INC (XSNX) recorded an outflow of $215K in operating cash flow during fiscal year 2024, representing cash used by core business activities.
What are NOVACCESS GLOBAL INC's total assets?
NOVACCESS GLOBAL INC (XSNX) had $62K in total assets as of fiscal year 2024, including both current and long-term assets.
How much does NOVACCESS GLOBAL INC spend on research and development?
NOVACCESS GLOBAL INC (XSNX) invested $154K in research and development during fiscal year 2024.
What is NOVACCESS GLOBAL INC's current ratio?
NOVACCESS GLOBAL INC (XSNX) had a current ratio of 0.01 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is NOVACCESS GLOBAL INC's P/E ratio?
NOVACCESS GLOBAL INC (XSNX) has no price-to-earnings ratio at the moment: no net income reported. The market capitalization is $6K as of Oct 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is NOVACCESS GLOBAL INC's price-to-sales ratio?
NOVACCESS GLOBAL INC (XSNX) has no price-to-sales ratio at the moment: revenue is not positive (FY2024). The market capitalization is $6K as of Oct 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does NOVACCESS GLOBAL INC's liquidity compare with its operating cash outflow?
At the end of fiscal year 2024, NOVACCESS GLOBAL INC (XSNX) held $21K in cash, cash equivalents and investments, and reported an operating cash outflow of $215K over that year. Dividing the one by the other, the reported balance equals about 1 month of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is NOVACCESS GLOBAL INC's debt-to-equity ratio negative or not reported?
NOVACCESS GLOBAL INC (XSNX) has negative shareholder equity of -$10.0M as of fiscal year 2024, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.